Practice Preferences on Dabigatran and Rivaroxaban for Stroke Prevention in Patients with Non-valvular Atrial Fibrillation
![]() |
Park, You Kyung
(Department of Pharmacy, Seoul St. Mary's Hospital)
Kang, Ji Eun (College of Pharmacy & Division of Life and Pharmaceutical Sciences, Ewha Womans University) Kim, Seong Joon (Albany College of Pharmacy and Health Sciences) La, Hyen O (Department of Pharmacology, School of Medicine, The Catholic University of Korea) Rhie, Sandy Jeong (Graduate School of Clinical Health Sciences, Ewha Womans University) |
1 | Culebras A, Messe SR, Chaturvedi et al. Summary of evidence-based guideline update: prevention of stroke in nonvalvular atrial fibrillation:report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology 2014;82(8):716-24. DOI |
2 | Mohanty BD, Looser PM, Gokanapudy LR, et al. Controversies regarding the new oral anticoagulants for stroke prevention in patients with atrial fibrillation. Vasc Med 2014;19(3):190-204. DOI |
3 | Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics--2012 update: a report from the American Heart Association. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circ 2012;125(1):e2-e220. DOI |
4 | Aguilar MI, Hart R. Oral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks. Cochrane Data System Rev 2005;3: Art. No. CD001927. |
5 | Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 2007;146(12):857-67. DOI |
6 | Shin HW, Kim YN, Bae HJ, et al. Trends in oral anticoagulation therapy among Korean patients with atrial fibrillation: The KORean Atrial Fibrillation Investigation. Korean Circ J 2012;42(2):113-7. DOI |
7 | Ezekowitz MD, Connolly SJ, Parekh A, et al. Rationale and design of RE-LY: randomized evaluation of long-term anticoagulant therapy, warfarin, compared with dabigatran. Am Heart J 2009;157:805-10. DOI |
8 | Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009;361:1139-51. DOI |
9 | Connolly SJ, Ezekowitz MD, Yusuf S, et al. Newly identified events in the RE-LY(R) trial. N Engl J Med 2010;363(19):1875-6. DOI |
10 | ROCKET AF Study Investigators. Rivaroxaban-once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation: rationale and design of the ROCKET AF study. Am Heart J 2010;159(3):340-7. DOI |
11 | Giugliano RP, Ruff CT, Braunwald E, et al. Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2013;369(22):2093-104. DOI |
12 | Patel MR, Mahaffey KW, Garg J, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 2011;365(10):883-91. DOI |
13 | Lopes RD, Alexander JH, Al-Khatib SM, et al. Apixaban for reduction in stroke and other Thromboembolic events in atrial fibrillation (ARISTOTLE) trial: design and rationale. Am Heart J 2010;159:331-9. DOI |
14 | Granger CB, Alexander JH, McMurray JJ, et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2011;365(11):981-92. DOI |
15 | Wong KS, Hu DY, Oomman A, et al. Rivaroxaban for stroke prevention in East Asian patients from the ROCKET AF trial. Stroke 2014;45(6):1739-47. DOI |
16 | Mismetti P, Laporte S. Rivaroxaban: clinical pharmacology. Ann Fr Anesth Reanim 2008; 27(Suppl3):516-21. DOI |
17 | Bytzer P, Connolly SJ, Yang S, et al. Analysis of upper gastrointestinal adverse events among patients given dabigatran in the RE-LY trial. Clin Gastroenterol Hepatol 2013;11(3):246-52.e5. DOI |
18 | U.S. Food and Drug Administration. Pradaxa (dabigatran):drug safety communication-lower risk for stroke and death, but higher risk for GI bleeding compared to warfarin. page last Updated: 05/13/2014. Available from http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm397179.htm. Accessed August 26, 2016. |
![]() |